France to End Homeopathy Funding
- Boiron shares fall further after Paris decision on remedies
- Company calls move ‘incomprehensible’ amid alternatives push
Photographer: Philippe Huguen/AFP via Getty Images
This article is for subscribers only.
France will stop funding the homeopathic pills and tinctures made by Boiron SA and rivals at the start of 2021, following the advice of a health panel that spent months reviewing the medicines.
Boiron Chief Executive Officer Valerie Poinsot has said that sales of reimbursed treatments could plummet by 50% in France, where the company brings in almost half its revenue, and at least 1,000 jobs hang in the balance.